Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 04, 2026 Filed Aug 5, 2026 20:23 UTC |
Har Even YoavDirector
|
GrantOrdinary Shares | 90,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-003871 · ownership.xml · nonDerivative · entry 1 Har Even Yoav · CIK 0002145803 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,162 F1 · shares: Represents 90,162 Restricted Share Units (RSUs) granted on August 4, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. F1 · balance_after: Represents 90,162 Restricted Share Units (RSUs) granted on August 4, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. Read SEC document |
| August 04, 2026 Filed Aug 5, 2026 20:21 UTC |
Luski IdoChief Operating Officer
|
GrantShare Option · Derivative | 69,296 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001178913-26-003869 · ownership.xml · derivative · entry 2 Luski Ido · CIK 0002087694 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,296 Underlying: Ordinary Shares · 69,296 shares Expires 2033-08-04 F4 · derivative.exercise_date: Share options granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Read SEC document |
| August 04, 2026 Filed Aug 5, 2026 20:21 UTC |
Luski IdoChief Operating Officer
|
GrantOrdinary Shares | 64,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-003869 · ownership.xml · nonDerivative · entry 1 Luski Ido · CIK 0002087694 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 393,701 F1 · shares: Represents 64,688 Restricted Share Units (RSUs) granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. F2 · balance_after: Includes 230,260 ordinary shares issuable upon vesting of RSUs; of which (a) 1,949 RSUs granted August 9, 2022, vesting quarterly through 2026; (b) 8,304 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 9,803 RSUs granted February 27, 2024, with 1,956 vesting quarterly through 2027 and 7,847 vesting quarterly through 2028; (d) 19,089 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 13,343 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 66,252 RSUs granted August 5, 2025, vesting quarterly through 2029; (g) 46,832 RSUs granted November 11, 2025, one-fourth vesting on November 11, 2026, remainder vesting quarterly through 2029; and (h) 64,688 RSUs granted August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030. F3 · balance_after: Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share. Read SEC document |
| August 04, 2026 Filed Aug 5, 2026 20:19 UTC |
Cegla Eldar MordechayChief Financial Officer
|
GrantShare Option · Derivative | 78,416 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001178913-26-003867 · ownership.xml · derivative · entry 2 Cegla Eldar Mordechay · CIK 0001964080 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,416 Underlying: Ordinary Shares · 78,416 shares Expires 2033-08-04 F4 · derivative.exercise_date: Share options granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Read SEC document |
| August 04, 2026 Filed Aug 5, 2026 20:19 UTC |
Cegla Eldar MordechayChief Financial Officer
|
GrantOrdinary Shares | 73,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-003867 · ownership.xml · nonDerivative · entry 1 Cegla Eldar Mordechay · CIK 0001964080 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 537,237 F1 · shares: Represents 73,184 Restricted Share Units (RSUs) granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. F2 · balance_after: Includes 234,628 ordinary shares issuable upon vesting of RSUs; of which (a) 2,607 RSUs granted August 9, 2022, vesting quarterly through 2026; (b) 11,104 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 13,109 RSUs granted February 27, 2024, with 2,616 vesting quarterly through 2027 and 10,493 vesting quarterly through 2028; (d) 25,524 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 15,092 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 41,016 RSUs granted August 5, 2025, vesting quarterly through 2029; (g) 52,992 RSUs granted November 11, 2025, one-fourth vesting on November 11, 2026, remainder vesting quarterly through 2029; and (h) 73,184 RSUs granted August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030. F3 · balance_after: Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share. Read SEC document |
| August 04, 2026 Filed Aug 5, 2026 20:16 UTC |
Hofstetter Elad BenChief Business Officer
|
GrantShare Option · Derivative | 57,968 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001178913-26-003865 · ownership.xml · derivative · entry 2 Hofstetter Elad Ben · CIK 0002030148 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,968 Underlying: Ordinary Shares · 57,968 shares Expires 2033-08-04 F4 · derivative.exercise_date: Share options granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Read SEC document |
| August 04, 2026 Filed Aug 5, 2026 20:16 UTC |
Hofstetter Elad BenChief Business Officer
|
GrantOrdinary Shares | 54,112 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-003865 · ownership.xml · nonDerivative · entry 1 Hofstetter Elad Ben · CIK 0002030148 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 286,256 F1 · shares: Represents 54,112 Restricted Share Units (RSUs) granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. F2 · balance_after: Includes 176,964 ordinary shares issuable upon vesting of RSUs; of which (a) 1,782 RSUs granted August 9, 2022, vesting quarterly through 2026; (b) 7,592 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 10,454 RSUs granted February 27, 2024, with 1,788 vesting quarterly through 2027 and 8,666 vesting quarterly through 2028; (d) 21,087 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 11,341 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 30,804 RSUs granted August 5, 2025, vesting quarterly through 2029; (g) 39,792 RSUs granted November 11, 2025, one-fourth vesting on November 11, 2026, remainder vesting quarterly through 2029; and (h) 54,112 RSUs granted August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030. F3 · balance_after: Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share. Read SEC document |
| August 04, 2026 Filed Aug 5, 2026 20:13 UTC |
Moscovici Avishay BenChief R&D Officer
|
GrantShare Option · Derivative | 71,072 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001178913-26-003863 · ownership.xml · derivative · entry 2 Moscovici Avishay Ben · CIK 0002030150 · Chief R&D Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,072 Underlying: Ordinary Shares · 71,072 shares Expires 2033-08-04 F4 · derivative.exercise_date: Share options granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Read SEC document |
| August 04, 2026 Filed Aug 5, 2026 20:13 UTC |
Moscovici Avishay BenChief R&D Officer
|
GrantOrdinary Shares | 66,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-003863 · ownership.xml · nonDerivative · entry 1 Moscovici Avishay Ben · CIK 0002030150 · Chief R&D Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 397,001 F1 · shares: Represents 66,336 Restricted Share Units (RSUs) granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. F2 · balance_after: Includes 213,724 ordinary shares issuable upon vesting of RSUs; of which (a) 2,005 RSUs granted August 9, 2022, vesting quarterly through 2026; (b) 8,540 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 12,471 RSUs granted February 27, 2024, with 2,013 vesting quarterly through 2027 and 10,458 vesting quarterly through 2028; (d) 25,452 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 13,684 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 37,188 RSUs granted August 5, 2025, vesting quarterly through 2029; (g) 48,048 RSUs granted November 11, 2025, one-fourth vesting on November 11, 2026, remainder vesting quarterly through 2029; and (h) 66,336 RSUs granted August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030. F3 · balance_after: Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share. Read SEC document |
| July 07, 2026 Filed Jul 9, 2026 10:01 UTC |
Keilaf Omer DavidDirector · Chief Executive Officer
|
OtherShare Option · Derivative | 25,641 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0001178913-26-003450 · zk2635665.xml · derivative · entry 5 Keilaf Omer David · CIK 0001964231 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,575 Underlying: Ordinary Shares · 25,641 shares Expires 2030-08-01 F6 · security: Share options granted on August 1, 2023. The balance reported includes 54,945 vested options and 36,630 unvested options, which shall vest in equal quarterly installments through 2027, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. F1 · shares: Represents a transfer of an aggregate of 679,400 ordinary shares and options to purchase an aggregate of 907,511 ordinary shares from the Reporting Person to his former spouse, Ms. Gali Moscovici, for no consideration, pursuant to a divorce settlement. The transferred ordinary shares consist of shares previously issued to the Reporting Person upon vesting and settlement of restricted share units, and the transferred options are reported in Table II. F6 · derivative.exercise_date: Share options granted on August 1, 2023. The balance reported includes 54,945 vested options and 36,630 unvested options, which shall vest in equal quarterly installments through 2027, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Read SEC document |
| July 07, 2026 Filed Jul 9, 2026 10:01 UTC |
Keilaf Omer DavidDirector · Chief Executive Officer
|
OtherShare Option · Derivative | 29,240 | $0.00 Strike: $5.23 | $0.00 |
DisclosureSEC source: 0001178913-26-003450 · zk2635665.xml · derivative · entry 4 Keilaf Omer David · CIK 0001964231 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,328 Underlying: Ordinary Shares · 29,240 shares Expires 2029-08-09 F5 · security: Share options granted on August 9, 2022. The balance reported includes 58,480 vested options and 5,848 unvested options, which shall vest in equal quarterly installments through 2026, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. F1 · shares: Represents a transfer of an aggregate of 679,400 ordinary shares and options to purchase an aggregate of 907,511 ordinary shares from the Reporting Person to his former spouse, Ms. Gali Moscovici, for no consideration, pursuant to a divorce settlement. The transferred ordinary shares consist of shares previously issued to the Reporting Person upon vesting and settlement of restricted share units, and the transferred options are reported in Table II. F5 · derivative.exercise_date: Share options granted on August 9, 2022. The balance reported includes 58,480 vested options and 5,848 unvested options, which shall vest in equal quarterly installments through 2026, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Read SEC document |
| July 07, 2026 Filed Jul 9, 2026 10:01 UTC |
Keilaf Omer DavidDirector · Chief Executive Officer
|
OtherShare Option · Derivative | 342,408 | $0.00 Strike: $9.92 | $0.00 |
DisclosureSEC source: 0001178913-26-003450 · zk2635665.xml · derivative · entry 3 Keilaf Omer David · CIK 0001964231 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 342,408 Underlying: Ordinary Shares · 342,408 shares Expires 2028-05-12 F4 · security: Immediately exercisable. F1 · shares: Represents a transfer of an aggregate of 679,400 ordinary shares and options to purchase an aggregate of 907,511 ordinary shares from the Reporting Person to his former spouse, Ms. Gali Moscovici, for no consideration, pursuant to a divorce settlement. The transferred ordinary shares consist of shares previously issued to the Reporting Person upon vesting and settlement of restricted share units, and the transferred options are reported in Table II. F4 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| July 07, 2026 Filed Jul 9, 2026 10:01 UTC |
Keilaf Omer DavidDirector · Chief Executive Officer
|
OtherShare Option · Derivative | 510,222 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001178913-26-003450 · zk2635665.xml · derivative · entry 2 Keilaf Omer David · CIK 0001964231 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 510,222 Underlying: Ordinary Shares · 510,222 shares Expires 2028-05-12 F4 · security: Immediately exercisable. F1 · shares: Represents a transfer of an aggregate of 679,400 ordinary shares and options to purchase an aggregate of 907,511 ordinary shares from the Reporting Person to his former spouse, Ms. Gali Moscovici, for no consideration, pursuant to a divorce settlement. The transferred ordinary shares consist of shares previously issued to the Reporting Person upon vesting and settlement of restricted share units, and the transferred options are reported in Table II. F4 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| July 07, 2026 Filed Jul 9, 2026 10:01 UTC |
Keilaf Omer DavidDirector · Chief Executive Officer
|
OtherOrdinary Shares | 679,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-003450 · zk2635665.xml · nonDerivative · entry 1 Keilaf Omer David · CIK 0001964231 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,826,531 F1 · balance_after: Represents a transfer of an aggregate of 679,400 ordinary shares and options to purchase an aggregate of 907,511 ordinary shares from the Reporting Person to his former spouse, Ms. Gali Moscovici, for no consideration, pursuant to a divorce settlement. The transferred ordinary shares consist of shares previously issued to the Reporting Person upon vesting and settlement of restricted share units, and the transferred options are reported in Table II. F2 · balance_after: The amount includes 916,552 ordinary shares issuable upon vesting of restricted share units ("RSUs"); of which (a) 7,798 RSUs granted August 9, 2022, vesting in equal quarterly installments through 2026; (b) 36,630 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 62,978 RSUs granted February 27, 2024, with 10,674 vesting quarterly through 2027 and 52,304 vesting quarterly through 2028; (d) 54,531 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 75,251 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 562,500 RSUs granted May 26, 2025, vesting quarterly through 2029; and (g) 116,864 RSUs granted August 5, 2025, one-fourth vesting on August 5, 2026, remainder vesting quarterly through 2029. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share. F3 · balance_after: No consideration was paid in connection with the transfer. No exercise price is applicable. Read SEC document |
| May 13, 2026 Filed May 15, 2026 10:14 UTC |
Jacoby StefanDirector
|
GrantOrdinary Shares | 110,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-002723 · ownership.xml · nonDerivative · entry 1 Jacoby Stefan · CIK 0001583553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,994 F1 · shares: Represents 110,668 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. F2 · balance_after: Includes 181,326 ordinary shares. Read SEC document |
| May 13, 2026 Filed May 15, 2026 10:05 UTC |
Steimberg AmichaiDirector
|
GrantOrdinary Shares | 265,602 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-002713 · ownership.xml · nonDerivative · entry 1 Steimberg Amichai · CIK 0001771362 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 989,336 F1 · shares: Represents 265,602 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. F2 · balance_after: Includes 723,734 ordinary shares. Read SEC document |
| May 13, 2026 Filed May 15, 2026 10:13 UTC |
Maor Shenaar RonitDirector
|
GrantOrdinary Shares | 110,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-002721 · ownership.xml · nonDerivative · entry 1 Maor Shenaar Ronit · CIK 0001965194 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 344,997 F1 · shares: Represents 110,668 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. F2 · balance_after: Includes 234,329 ordinary shares. Read SEC document |
| May 13, 2026 Filed May 15, 2026 10:11 UTC |
Stav OritDirector
|
GrantOrdinary Shares | 110,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-002719 · ownership.xml · nonDerivative · entry 1 Stav Orit · CIK 0001965230 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 344,997 F1 · shares: Represents 110,668 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. F2 · balance_after: Includes 234,329 ordinary shares. Read SEC document |
| May 13, 2026 Filed May 15, 2026 10:09 UTC |
Sheridan James J. IIIDirector
|
GrantOrdinary Shares | 110,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-002717 · ownership.xml · nonDerivative · entry 1 Sheridan James J. III · CIK 0001891058 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 427,397 F1 · shares: Represents 110,668 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. F2 · balance_after: Includes 234,329 ordinary shares held directly by Mr. Sheridan, and 82,400 ordinary shares held by Perception Capital Partners, LLC. Mr. Sheridan is a director appointed by Perception Capital Partners, LLC and may be deemed to be the beneficial owner of the securities held by Perception Capital Partners, LLC. F2 · ownership.direct: Includes 234,329 ordinary shares held directly by Mr. Sheridan, and 82,400 ordinary shares held by Perception Capital Partners, LLC. Mr. Sheridan is a director appointed by Perception Capital Partners, LLC and may be deemed to be the beneficial owner of the securities held by Perception Capital Partners, LLC. Read SEC document |
| May 13, 2026 Filed May 15, 2026 10:07 UTC |
Falk Dan MichaelDirector
|
GrantOrdinary Shares | 110,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-002715 · ownership.xml · nonDerivative · entry 1 Falk Dan Michael · CIK 0001966097 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 344,997 F1 · shares: Represents 110,668 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. F2 · balance_after: Includes 234,329 ordinary shares. Read SEC document |
| May 13, 2026 Filed May 15, 2026 10:03 UTC | GrantOrdinary Shares | 110,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-002711 · ownership.xml · nonDerivative · entry 1 Von Witzleben Alexander Reymar Karl-Wilhelm · CIK 0002023671 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 296,768 F1 · shares: Represents 110,668 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. F2 · balance_after: Includes 186,100 ordinary shares. Read SEC document |
|
| May 13, 2026 Filed May 15, 2026 10:01 UTC |
Aharon AharonDirector
|
GrantOrdinary Shares | 110,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-002709 · ownership.xml · nonDerivative · entry 1 Aharon Aharon · CIK 0001966840 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 344,997 F1 · shares: Represents 110,668 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. F2 · balance_after: Includes 234,329 ordinary shares. Read SEC document |
| April 30, 2026 Filed May 4, 2026 12:49 UTC |
Keilaf Omer DavidDirector · Chief Executive Officer
|
OtherOrdinary Shares | 723,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-002357 · zk2635194.xml · nonDerivative · entry 1 Keilaf Omer David · CIK 0001964231 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,505,931 F1 · balance_after: Represents a transfer of 723,019 ordinary shares from the Reporting Person to his former spouse, Ms. Gali Moscovici, pursuant to a divorce settlement. F2 · balance_after: The amount includes 1,135,780 ordinary shares issuable upon vesting of restricted share units ("RSUs"); of which (a) 15,596 RSUs granted August 9, 2022, vesting in equal quarterly installments through 2026; (b) 36,630 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 74,008 RSUs granted February 27, 2024, with 14,232 vesting quarterly through 2027 and 59,776 vesting quarterly through 2028; (d) 60,590 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 82,092 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 750,000 RSUs granted May 26, 2025, one-fourth vesting on May 26, 2026, remainder vesting quarterly through 2029; and (g) 116,864 RSUs granted August 5, 2025, one-fourth vesting on August 5, 2026, remainder vesting quarterly through 2029. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share. F3 · balance_after: No exercise price is applicable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.